Linkedin
Sign in
Thought Leadership
Healthcare C-Suite Movements
Digital in Pharma
Events
FFE+CEO RT
BrandStorm
Solutions & Pricing
Partner
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Type here...
Search
Home
About
Editor’s Corner
Contribute
Contact Us
Thought Leadership
Healthcare C-Suite Movements
Digital in Pharma
Events
Solutions & Pricing
Partner
Instagram
Linkedin
Twitter
Subscribe
Subscribe
Wednesday, April 22, 2026
29.4
C
Bengaluru
Home
About
Editor’s Corner
Contribute
Contact Us
My account
Get into your account.
Login
Register
type here...
Search
Facebook
Linkedin
Twitter
Youtube
Thought Leadership
Healthcare C-Suite Movements
Digital in Pharma
Events
FFE+CEO RT
BrandStorm
Solutions & Pricing
Partner
Hot topics
Biocon Biologics Scores FDA Approval—A Biosimilar Shake-Up for Amgen, Patients, and Investors
0
Biocon Biologics secures FDA approval for Bosayaâ„¢ and Aukelsoâ„¢,...
The Quiet Crisis in the Indian Pharma Field Force
0
A MedicinMan Editorial based on the Poll framed by...
A Tale of Two Companies – Sun Pharma’s Odyssey and Organon’s Second Act
0
Sun Pharma’s Odyssey and Organon’s Second Act – And...
Why the World Still Doesn’t Celebrate Antibiotic Breakthroughs llike Zaynich
0
When a new cancer drug shows promise, it trends...
Zaynich and the $9 Billion Moment: A New Dawn for Indian Pharma?
0
A quiet but revolutionary milestone may be unfolding in...
Facebook
Linkedin
Twitter
Youtube
Healthcare Trends
Will the GLP Battle Now Shift from Injectable to Oral?
0
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap
0
The Semaglutide Shift: From Blockbuster to Commodity Why the $50...
Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy
0
In 1989, oncology in India was not a business...
Ritesh Desai has joined Standard Chartered India as Executive Director
0
Ritesh Desai has joined Standard Chartered India as Executive...
The Healthium Odyssey: From Sutures to Scalpel-Sharp Innovation
0
The story of Healthium is not just one of...
Marketing
Will the GLP Battle Now Shift from Injectable to Oral?
0
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap
0
The Semaglutide Shift: From Blockbuster to Commodity Why the $50...
Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy
0
In 1989, oncology in India was not a business...
Ritesh Desai has joined Standard Chartered India as Executive Director
0
Ritesh Desai has joined Standard Chartered India as Executive...
The Healthium Odyssey: From Sutures to Scalpel-Sharp Innovation
0
The story of Healthium is not just one of...
Policies/Sales
Will the GLP Battle Now Shift from Injectable to Oral?
0
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap
0
The Semaglutide Shift: From Blockbuster to Commodity Why the $50...
Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy
0
In 1989, oncology in India was not a business...
Ritesh Desai has joined Standard Chartered India as Executive Director
0
Ritesh Desai has joined Standard Chartered India as Executive...
The Healthium Odyssey: From Sutures to Scalpel-Sharp Innovation
0
The story of Healthium is not just one of...
Strategy
Will the GLP Battle Now Shift from Injectable to Oral?
0
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap
0
The Semaglutide Shift: From Blockbuster to Commodity Why the $50...
Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy
0
In 1989, oncology in India was not a business...
Ritesh Desai has joined Standard Chartered India as Executive Director
0
Ritesh Desai has joined Standard Chartered India as Executive...
The Healthium Odyssey: From Sutures to Scalpel-Sharp Innovation
0
The story of Healthium is not just one of...
Subscribe
Thought Leadership
Healthcare C-Suite Movements
Digital in Pharma
Events
FFE+CEO RT
BrandStorm
Solutions & Pricing
Partner
Hot topics
Blinkit, Zepto, Instamart: Who Will Own India’s At‑Home Diagnostics Market?
0
India’s diagnostics market is undergoing a quiet but profound...
DeepSeek – A Precursor to Patent Disruption?
0
The rise of open-source platforms, such as China’s DeepSeek...
Indian #Pharma Market (IPM) – August 2020 Sales
0
The COVID crisis has impacted IPM negatively - the...
Crafting a Digital Strategy
0
A Digital-in-pharma special issue. Announcement for ACG-MedicinMan's "Pharmaceutical Marketing in the New Age" conference to be held in March 2018
Nimesulide – Nice or Not Nise?
0
Nimesulide Regulatory Status Worldwide Nimesulide is a non-steroidal anti-inflammatory drug...
Facebook
Linkedin
Twitter
Youtube
Healthcare Trends
Will the GLP Battle Now Shift from Injectable to Oral?
0
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap
0
The Semaglutide Shift: From Blockbuster to Commodity Why the $50...
Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy
0
In 1989, oncology in India was not a business...
Ritesh Desai has joined Standard Chartered India as Executive Director
0
Ritesh Desai has joined Standard Chartered India as Executive...
The Healthium Odyssey: From Sutures to Scalpel-Sharp Innovation
0
The story of Healthium is not just one of...
Marketing
Will the GLP Battle Now Shift from Injectable to Oral?
0
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap
0
The Semaglutide Shift: From Blockbuster to Commodity Why the $50...
Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy
0
In 1989, oncology in India was not a business...
Ritesh Desai has joined Standard Chartered India as Executive Director
0
Ritesh Desai has joined Standard Chartered India as Executive...
The Healthium Odyssey: From Sutures to Scalpel-Sharp Innovation
0
The story of Healthium is not just one of...
Policies/Sales
Will the GLP Battle Now Shift from Injectable to Oral?
0
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap
0
The Semaglutide Shift: From Blockbuster to Commodity Why the $50...
Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy
0
In 1989, oncology in India was not a business...
Ritesh Desai has joined Standard Chartered India as Executive Director
0
Ritesh Desai has joined Standard Chartered India as Executive...
The Healthium Odyssey: From Sutures to Scalpel-Sharp Innovation
0
The story of Healthium is not just one of...
Strategy
Will the GLP Battle Now Shift from Injectable to Oral?
0
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap
0
The Semaglutide Shift: From Blockbuster to Commodity Why the $50...
Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy
0
In 1989, oncology in India was not a business...
Ritesh Desai has joined Standard Chartered India as Executive Director
0
Ritesh Desai has joined Standard Chartered India as Executive...
The Healthium Odyssey: From Sutures to Scalpel-Sharp Innovation
0
The story of Healthium is not just one of...
Subscribe
DSC_6697